Body mass index and major cardiovascular events after myocardial infarction: a nationwide registry study
Authors:
Open Access
- 5 August 2026
- journal article
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
Abstract
Aims: The ‘obesity paradox’ suggests lower cardiovascular risk at higher body mass index (BMI) after myocardial infarction (MI), but whether it reflects true protection or methodological bias is unclear. Methods and results: From the nationwide SWEDEHEART registry, patients hospitalized with MI from 2010 to 2021 were included. BMI at admission was modelled both as a continuous variable using restricted cubic splines and categorized into six groups, with 20 to <25 kg/m2 as reference. The primary outcome was major adverse cardiovascular events (MACE), a composite of recurrent MI, stroke, heart failure hospitalization, or cardiovascular death. Cox regression models estimated the BMI associated with lowest risk and HRs for categorical BMI groups. Adjustments included sociodemographic factors, smoking, and comorbidities not attributed to obesity. Mediation analyses assessed the roles of diabetes, hypertension, and prior cardiovascular disease. In 173 617 patients, the mean age was 71.0 years, 66.7% were men, and mean BMI was 27.1 kg/m2. During a median follow-up of 3.3 years, 36.5% experienced MACE. BMI had a U-shaped association with MACE, with the lowest risk at BMI 25.1 kg/m2. The adjusted HR (95% CI) for MACE was 0.99 (0.97–1.01) for overweight and 1.17 (1.14–1.20) for obesity class I, increasing across higher obesity classes. Excess risk was largely mediated by diabetes, hypertension, and prior cardiovascular disease. Conclusion: Obesity was associated with increased risk of MACE, partly mediated by obesity-related risk factors. The findings suggest that previously reported ‘obesity paradoxes’ may reflect differences in confounder adjustment, handling of mediators, patient populations, and survivor bias.Keywords
This publication has 32 references indexed in Scilit:
- The Obesity Paradox of Cardiovascular Outcomes in Patients with Diabetes MellitusCurrent Diabetes Reports, 2025
- Data quality assessment in the SWEDEHEART registry: Insights from serial audits on completeness and accuracyAmerican Heart Journal, 2025
- Glucagon‐Like Peptide‐1 Receptor Agonists and Major Adverse Cardiovascular Events in Patients With and Without Diabetes: A Meta‐Analysis of Randomized‐Controlled TrialsClinical Cardiology, 2024
- Cardiovascular Benefits of GLP-1 Receptor Agonists in Patients Living with Obesity or Overweight: A Meta-analysis of Randomized Controlled TrialsAmerican Journal of Cardiovascular Drugs, 2024
- Major Adverse Cardiovascular Events Among Obese Patients with Diabetes After Metabolic and Bariatric Surgery: a Meta-analysis of Matched Cohort and Prospective Controlled Studies with 122,361 ParticipatesObesity Surgery, 2023
- The Relationship of Body Mass Index to Percutaneous Coronary Intervention OutcomesJACC: Cardiovascular Interventions, 2017
- The obesity paradox in acute coronary syndrome: a meta-analysisEuropean Journal of Epidemiology, 2014
- Bariatric surgery and its impact on cardiovascular disease and mortality: A systematic review and meta-analysisInternational Journal of Cardiology, 2014
- No Evidence of “Obesity Paradox” After Treatment With Drug-Eluting Stents in a Routine Clinical PracticeJACC: Cardiovascular Interventions, 2012
- Excess weight at time of presentation of myocardial infarction is associated with lower initial mortality risks but higher long-term risks including recurrent re-infarction and cardiac deathInternational Journal of Cardiology, 2006